Quick Answer
ACADIA PHARMACEUTICALS INC reported Cash And Cash Equivalents At Carrying Value of $177.70 million for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed a decrease of -44.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), ACADIA PHARMACEUTICALS INC's Cash And Cash Equivalents At Carrying Value has grown by 2,494.5%.
- Historical annual values: Fiscal year 2025: $177.70 million | Fiscal year 2024: $319.59 million | Fiscal year 2023: $188.66 million | Fiscal year 2022: $114.85 million | Fiscal year 2021: $147.44 million | Fiscal year 2020: $326.03 million | Fiscal year 2019: $189.68 million | Fiscal year 2018: $134.76 million | Fiscal year 2017: $69.42 million | Fiscal year 2016: $163.62 million | Fiscal year 2015: $102.14 million | Fiscal year 2014: $61.85 million | Fiscal year 2013: $11.71 million | Fiscal year 2012: $57.90 million | Fiscal year 2011: $6.89 million | Fiscal year 2010: $6.85 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: